Barbra Richardson, PhD

Research Professor, Department of Biostatistics

Dr. Barbra Richardson, PhD, is a Research Professor in the Department of Biostatistics and an Adjunct Research Professor in the Department of Global Health at the University of Washington School of Public Health and Community Medicine. She is also a Joint Member at the Fred Hutchinson Cancer Research Center. Dr. Richardson received her PhD in Biostatistics from UCLA in 1993, was a postdoctoral fellow at University of Washington from 1993 to 1996, and joined the faculty of UW in 1996. She has been involved in clinical trials and HIV/AIDS and microbicide research since 1993 and is an author on over 250 peer-reviewed articles in the areas of HIV/AIDS, other sexually transmitted diseases, and statistical methodology for data from infectious disease research. Dr. Richardson has significantly contributed to the design of several HIV prevention research trials and cohort studies, including preparedness studies, safety studies (Phase I and II), and efficacy trials (Phase IIB and III). Finally, Dr. Richardson, a recipient of the International AIDS Society (IAS) Young Investigator award (2000), has been a member of several national and international review committees, and has advised various entities (including the World Health Organization (WHO)) on statistical issues in infectious disease.

Publications

  1. Žuštra, A, Leonard, VR, Holland, LA, Hu, JC, Mu, T, Holland, SC et al.. Longitudinal dynamics of the nasopharyngeal microbiome in response to SARS-CoV-2 Omicron variant and HIV infection in Kenyan women and their children. mSystems. 2025;10 (5):e0156824. doi: 10.1128/msystems.01568-24. PubMed PMID:40261064 PubMed Central PMC12090742.
  2. Unger, JA, Kinuthia, J, Wandika, B, Hedstrom, A, Wetzler, E, Udren, JI et al.. The impact of interactive text communication on neonatal mortality in Kenya: a randomized controlled trial. Nat Med. 2025; :. doi: 10.1038/s41591-025-03576-z. PubMed PMID:40075230 .
  3. Gómez, L, Kinuthia, J, Abuna, F, Baeten, JM, Dettinger, J, Larsen, A et al.. Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social-emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study. Lancet Glob Health. 2025;13 (3):e467-e478. doi: 10.1016/S2214-109X(24)00471-6. PubMed PMID:40021305 PubMed Central PMC11964894.
  4. Saha, A, Escudero, JN, Layouni, T, Mecha, J, Maleche-Obimbo, E, Matemo, D et al.. Diminished Mycobacterium tuberculosis-specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy. Open Forum Infect Dis. 2025;12 (2):ofaf067. doi: 10.1093/ofid/ofaf067. PubMed PMID:39981072 PubMed Central PMC11842132.
  5. Noguchi, LM, Owor, M, Mgodi, NM, Gati Mirembe, B, Dadabhai, S, Horne, E et al.. Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial. Lancet HIV. 2025;12 (3):e180-e190. doi: 10.1016/S2352-3018(24)00306-0. PubMed PMID:39954697 .
Search PubMed

Comments are closed.